Figure 2
Figure 2. Tailoring of GVHD prophylaxis according to patient’s genetic lesions and other risk factors influencing the relapse rate. HSCT, hematopoietic stem cell transplantation; Bu, busulfan.

Tailoring of GVHD prophylaxis according to patient’s genetic lesions and other risk factors influencing the relapse rate. HSCT, hematopoietic stem cell transplantation; Bu, busulfan.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal